4
Changes in Ownership
Vor Biopharma Inc. Filed Acc 0001209191-21-008888
Director bought 555,555 shares at $18.00 ($9,999,990)
- Director acquired 6,136,874 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PARMAR KUSH Director | 2021-02-09 | Conversion | +3,308,822 | 3,308,822 | I: show line 1 in the form | ||
| PARMAR KUSH Director | 2021-02-09 | Conversion | +1,414,026 | 4,722,848 | I: show line 2 in the form | ||
| PARMAR KUSH Director | 2021-02-09 | Purchase | +111,111 | $18.00 | $1,999,998 | 4,833,959 | I: show line 3 in the form |
| PARMAR KUSH Director | 2021-02-09 | Conversion | +1,414,026 | 1,414,026 | I: show line 4 in the form | ||
| PARMAR KUSH Director | 2021-02-09 | Purchase | +444,444 | $18.00 | $7,999,992 | 1,858,470 | I: show line 5 in the form |
| Open-market purchases · 555,555 sh · avg $18.00 · $9,999,990 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PARMAR KUSH Director | 2021-02-05 | Grant or award · Stock Option (right to buy) | +16,900 | 16,900 | D: show line 6 in the form | ||
| PARMAR KUSH Director | 2021-02-09 | Conversion · Series A-2 Preferred Stock | −45,000,000 | 0 | I: show line 7 in the form | ||
| PARMAR KUSH Director | 2021-02-09 | Conversion · Series B Preferred Stock | −19,230,768 | 0 | I: show line 8 in the form | ||
| PARMAR KUSH Director | 2021-02-09 | Conversion · Series B Preferred Stock | −19,230,768 | 0 | I: show line 9 in the form |
Loading xslF345X03/doc4.xml…